Stay updated on Dupilumab Efficacy in Persistent Asthma Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Persistent Asthma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant revisions, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on dupilumab for asthma, while adding new identifiers and collaborators.SummaryDifference22%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to Dupilumab Efficacy in Persistent Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Persistent Asthma Clinical Trial page.